← Back to headlines
SkinBioTherapeutics Appoints Rachel Parsonage as Interim CEO
SkinBioTherapeutics has announced the appointment of Rachel Parsonage as its interim Chief Executive Officer, effective immediately.
2 Mar, 07:40 — 2 Mar, 07:40
ℹOnly 1 source covers this story
